| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 08/09/2001 | WO2000069895A3 Bufornin 1 as a specific inhibitor and therapeutic agent for botulinum toxin b and tetanus neurotoxins |
| 08/09/2001 | WO2000069257A3 Genetic modification of male germ cells for generation of transgenic species and genetic therapies |
| 08/09/2001 | WO2000063351A3 Carbohydrate-modifying enzymes |
| 08/09/2001 | WO2000061729A3 Regulation of the expression of transcriptional repressor genes using nucleic acid molecules |
| 08/09/2001 | WO2000058510A3 Schizophrenia associated genes, proteins and biallelic markers |
| 08/09/2001 | WO2000046599A9 System for producing morphological and functional changes in adult mammalian cells |
| 08/09/2001 | WO2000044882A3 Methods and compositions for the differentiation of human preadipocytes into adipocytes |
| 08/09/2001 | WO2000037643A3 Compounds for immunotherapy and diagnosis of colon cancer and methods for their use |
| 08/09/2001 | WO2000006713A3 Methods for recombinant protein production in mammalian cells comprising co-expression with fetuin |
| 08/09/2001 | US20010013134 Transgenic mammal; polynucleotide containing pancreas promoter |
| 08/09/2001 | US20010012965 In vitro production of transplantable cartilage tissue |
| 08/09/2001 | US20010012889 36 human secreted proteins |
| 08/09/2001 | US20010012836 Determining the presence or absence of a mutation in the nucleotide sequence or absence of a mutation in nucleotide sequence encoding the specific polypeptides in the genome of the subject and analyzing for presence of polypeptide |
| 08/09/2001 | US20010012831 Calcium-binding protein |
| 08/09/2001 | US20010012632 Dendritic-like cell/tumor cell hybrids and hybridomas for inducing an anti-tumor response |
| 08/09/2001 | US20010012627 Neurotransmitter transporter SC6 |
| 08/09/2001 | US20010012626 Polynucleotides encoding Presenilin 1 (PS1); diagnosing a patient having an increased likelihood of contracting Alzheimer's disease |
| 08/09/2001 | US20010012621 Determining the expression of lysyl oxidase, the expression of lysyl oxidase indicating that the compound is capable of suppressing ras functions |
| 08/09/2001 | US20010012619 Novel cancer drug screen based on cell cycle uncoupling |
| 08/09/2001 | US20010012610 Of biological specimens by true vitrification comprising dehydrating a biologically active material at a temperature higher than the suggested storage temperatures followed by cooling of the sample to the storage temperature |
| 08/09/2001 | US20010012516 Viral vectors |
| 08/09/2001 | US20010012513 Embryonic or stem-like cell lines produced by cross species nuclear transplantation |
| 08/09/2001 | EP1144611A3 Method for recombinant protein production in mammalian cells comprising co-expression with fetuin |
| 08/09/2001 | DE10003811A1 Verfahren zur Herstellung eines serumhaltigen Kulturmediums für Zellen sowie dessen Verwendung A process for producing a serum-containing culture medium for the cells and the use thereof |
| 08/09/2001 | DE10003521A1 Vorrichtung zum Herstellen eines dreidimensionalen Matrixkörpers, Multi-Well-Platte, Lösung zum Kultivieren von Säugerkardiomyocyten, Verfahren zum Kultivieren einer Zellkultur, Vorrichtung für die Messung isometrischer Kraftparameter von Zellkulturen sowie Verfahren zum meßbaren Verfolgen von Kontraktionen eines in eine Trägersubstanz eingelagerten Zellgewebes Apparatus for producing a three-dimensional matrix body, multi-well plate solution for culturing mammalian cardiomyocytes, methods for culturing a cell culture device for measuring isometric force parameters of cell cultures and methods for measurable following of contractions of an embedded into a carrier subcutaneous tissue |
| 08/09/2001 | CA2400013A1 Methods of protein destabilization and uses thereof |
| 08/09/2001 | CA2399982A1 G-protein coupled receptors |
| 08/09/2001 | CA2399686A1 Methods and materials relating to cub domain polypeptides and polynucleotides |
| 08/09/2001 | CA2399683A1 Mammalian sphingosine-1-phosphate phosphatase |
| 08/09/2001 | CA2399672A1 Methods and materials relating to metallocarboxypeptidase-like polypeptides and polynucleotides |
| 08/09/2001 | CA2399649A1 Methods and materials relating to leucine-rich repeat protein-like (lrr protein-like) polypeptides and polynucleotides |
| 08/09/2001 | CA2399644A1 Methods and materials relating to neurotrimin-like polypeptides and polynucleotides |
| 08/09/2001 | CA2399561A1 Ruminant mhc class i-like fc receptors |
| 08/09/2001 | CA2399267A1 Protein c derivatives |
| 08/09/2001 | CA2399149A1 Plant adpglucose pyrophosphatase, process for the production, use in themanufacture of assay devices and in producing transgenic plants |
| 08/09/2001 | CA2399080A1 Humanized anti-ccr2 antibodies and methods of use therefor |
| 08/09/2001 | CA2399032A1 Ligands for fpr class receptors that induce a host immune response to a pathogen or inhibit hiv infection |
| 08/09/2001 | CA2399022A1 Ligand for vascular endothelial growth factor receptor |
| 08/09/2001 | CA2398998A1 Cd40-binding apc-activating molecules |
| 08/09/2001 | CA2398678A1 Selective killing of cells by activation of double-stranded rna dependent protein kinase-pkr |
| 08/09/2001 | CA2398255A1 Bcl-2-like polynucleotides, polypeptides, and antibodies |
| 08/09/2001 | CA2398215A1 Methods and materials relating to preadipocyte factor-1-like (pref-1-like) polypeptides and polynucleotides |
| 08/09/2001 | CA2396774A1 Nucleic acid molecules encoding transmembrane serine proteases, the encoded proteins and methods based thereon |
| 08/08/2001 | EP1121852A1 Methods of enhancing vitality of plants, trees, and crops with stevia |
| 08/08/2001 | EP1121599A1 Detection and quantification of vancomycin in biological fluids |
| 08/08/2001 | EP1121593A2 Method for extracting quantitative information relating to an influence on a cellular response |
| 08/08/2001 | EP1121454A1 Extracellular novel rage binding protein (en-rage) and uses thereof |
| 08/08/2001 | EP1121449A1 Delivery system for porcine somatotropin |
| 08/08/2001 | EP1121448A1 EXPRESSION AND SECRETION OF icIL-1 RECEPTOR ANTAGONIST TYPE II |
| 08/08/2001 | EP1121447A2 Means and methods for modulating stomata characteristica in plants |
| 08/08/2001 | EP1121445A2 Specific genetic modification of the activity of trehalose-6-phosphate synthase and expression in a homologous or heterologous environment |
| 08/08/2001 | EP1121444A2 Protein kinase homologs |
| 08/08/2001 | EP1121443A1 Plant promoter |
| 08/08/2001 | EP1121441A2 Selectively replicating viral vectors |
| 08/08/2001 | EP1121437A2 Metastatic breast and colon cancer regulated genes |
| 08/08/2001 | EP1121433A2 Human ankyrin family protein |
| 08/08/2001 | EP1121432A2 G-protein-coupled receptor-like proteins, polynucleotides encoded by them, and methods of using same |
| 08/08/2001 | EP1121431A1 Non-endogenous, constitutively activated human g protein-coupled receptors |
| 08/08/2001 | EP1121430A1 Human isre-binding protein |
| 08/08/2001 | EP1121429A2 Gene therapy of alzheimer's disease by delivery of an encoded apolipoprotein e |
| 08/08/2001 | EP1121427A1 (mbp1) polypeptides capable of interacting with oncogenic mutants of the p53 protein |
| 08/08/2001 | EP1121425A1 Stabilized bioactive peptides and methods of identification, synthesis and use |
| 08/08/2001 | EP1121422A2 Terpene synthases |
| 08/08/2001 | EP1121421A1 Materials and methods for the modification of plant lignin content |
| 08/08/2001 | EP1121419A1 Tnfr related gene 12 |
| 08/08/2001 | EP1121418A1 A novel lymphocyte population expressing intracellular mo2 |
| 08/08/2001 | EP1121417A2 Chinese hamster ovary cells for producing proteins |
| 08/08/2001 | EP1121383A1 Methods for the production of antibodies to specific regions of cyclosporine and cyclosporine metabolites |
| 08/08/2001 | EP1121382A2 Interferon-beta fusion proteins and uses |
| 08/08/2001 | EP1121379A1 MAMMALIAN elk POTASSIUM CHANNEL GENES |
| 08/08/2001 | EP1121374A1 Bone morphogenic protein-induced genes and polypeptides, and their use in diagnostic and therapeutic methods |
| 08/08/2001 | EP1121157A1 A novel component in the hedgehog signalling pathway |
| 08/08/2001 | EP1121150A1 Delta 6 fatty acid desaturase |
| 08/08/2001 | EP1121137A1 Method for killing tumor and tumor associated endothelial cells using adenoviral mutants |
| 08/08/2001 | EP1121064A1 Method and device for preparing a dental implant by immersion in a mesenchymal cell culture |
| 08/08/2001 | EP0960118A4 Nucleotide and protein sequences of liver activin/inhibin and methods based thereon |
| 08/08/2001 | EP0815133A4 Human stat4 |
| 08/08/2001 | EP0786004B1 Cloning, expression and characterisation of a novel form of phosphatidylinositol-3-kinase |
| 08/08/2001 | EP0726949B1 Opioid receptor: compositions and methods |
| 08/08/2001 | EP0669829B1 Enhancement of xenograft tolerance and porcine cytokines therefor |
| 08/08/2001 | EP0641223B1 Biotherapeutic cell-coated microspheres |
| 08/08/2001 | CN1307643A Human BMP-7 promoter and method for exploring bone-related substance by using the same |
| 08/08/2001 | CN1307642A Method for producing polypeptide by modifying copy number of gene |
| 08/08/2001 | CN1307641A DSRNA-mediated regulation of gene expression in plants |
| 08/08/2001 | CN1307639A Pesticidal toxins and nucleotide sequences which encode there toxins |
| 08/08/2001 | CN1307638A Host-encoded protein expressed on Marek's disease (MDV)-infected cells and antibody thereto |
| 08/08/2001 | CN1307637A Polynucleotides isolated from skin cells and methods for their use |
| 08/08/2001 | CN1307636A Endometriosis-associated gene |
| 08/08/2001 | CN1307632A Ependymal neural stem cells and method for their isolation |
| 08/08/2001 | CN1307590A Treating and diagnosing macrophage-mediated diseases using FC receptor ligands |
| 08/08/2001 | CN1307587A Human BMP-4 promoter and method for exploring bone-related substance by using the same |
| 08/08/2001 | CN1307482A Utilization of interferon alpha 5 in the treatment of viral hepatopathies |
| 08/08/2001 | CN1307480A Fertility improving composition and application thereof |
| 08/08/2001 | CN1307473A Triterpene compositions and methods for use thereof |
| 08/08/2001 | CN1307137A Transgenic plant carrying neoxanthin lyase gene |
| 08/08/2001 | CN1307101A Method for construction of slow particle human primary dried archeocyte model and use thereof |
| 08/08/2001 | CN1307000A Vaccine for hoof-and-mouth disease and preparing method thereof |
| 08/08/2001 | CN1306859A Preparation of antineoplastic immune vaccine |
| 08/08/2001 | CN1069216C Process for production of attenuated varicella zoster virus vaccine |
| 08/07/2001 | USRE37317 Encoding acyl-acyl carrier protein thioesterase enzymes to modify plant lipid composition; chimeric genes and suitable regulatory sequences used to create transgenic plants with altered levels of saturated fatty acids |